Strain identifier

BacDive ID: 1693

Type strain: Yes

Species: Bifidobacterium bifidum

Strain Designation: Ti, Tissier

Strain history: CIP <- 1956, Lab. Ident. Inst. Pasteur, Paris, France <- A.R. Prévot, Inst. Pasteur, France: strain Tissier

NCBI tax ID(s): 500634 (strain), 1681 (species)

« back to strain detail view
For citation purpose refer to the digital object identifier (doi) of the current version.
Archive
version 9.3 (current version):
version 9.2:
version 9.1:
version 9:
version 8.1:
version 8:
version 7.1:
version 7:
version 6:
version 5:
version 4.1:
version 4:
version 3:
version 2.1:
version 2:
version 1:
version 9.3 (current version)

General

@ref: 8828

BacDive-ID: 1693

DSM-Number: 20456

keywords: genome sequence, 16S sequence, Bacteria, anaerobe, mesophilic, Gram-positive, rod-shaped

description: Bifidobacterium bifidum Ti is an anaerobe, mesophilic, Gram-positive bacterium that was isolated from stool of breast-fed infant.

NCBI tax id

NCBI tax idMatching level
1681species
500634strain

strain history

@refhistory
8828<- T. Mitsuoka <- Tissier, Ti
67770DSM 20456 <-- T. Mitsuoka 4-127 <-- H. Tissier strain Ti.
116806CIP <- 1956, Lab. Ident. Inst. Pasteur, Paris, France <- A.R. Prévot, Inst. Pasteur, France: strain Tissier

doi: 10.13145/bacdive1693.20250331.9.3

Name and taxonomic classification

LPSN

  • @ref: 20215
  • description: domain/bacteria
  • keyword: phylum/actinomycetota
  • domain: Bacteria
  • phylum: Actinomycetota
  • class: Actinomycetes
  • order: Bifidobacteriales
  • family: Bifidobacteriaceae
  • genus: Bifidobacterium
  • species: Bifidobacterium bifidum
  • full scientific name: Bifidobacterium bifidum (Tissier 1900) Orla-Jensen 1924 (Approved Lists 1980)

  • synonyms

    @refsynonym
    20215Bacterium bifidum
    20215Bacillus bifidus

@ref: 8828

domain: Bacteria

phylum: Actinobacteria

class: Actinobacteria

order: Bifidobacteriales

family: Bifidobacteriaceae

genus: Bifidobacterium

species: Bifidobacterium bifidum

full scientific name: Bifidobacterium bifidum (Tissier 1900) Orla-Jensen 1924 emend. Nouioui et al. 2018

strain designation: Ti, Tissier

type strain: yes

Morphology

cell morphology

@refgram staincell shapemotilityconfidence
116806positiverod-shapedno
125438no93

colony morphology

  • @ref: 116806

Culture and growth conditions

culture medium

@refnamegrowthlinkcomposition
8828BIFIDOBACTERIUM MEDIUM (DSMZ Medium 58)yeshttps://mediadive.dsmz.de/medium/58Name: BIFIDOBACTERIUM MEDIUM (DSMZ Medium 58) Composition: Glucose 10.0 g/l Casein peptone 10.0 g/l Bacto Soytone 5.0 g/l Meat extract 5.0 g/l Yeast extract 5.0 g/l L-Cysteine HCl x H2O 0.5 g/l NaHCO3 0.4 g/l NaCl 0.08 g/l MnSO4 x H2O 0.05 g/l KH2PO4 0.04 g/l K2HPO4 0.04 g/l MgSO4 x 7 H2O 0.02 g/l CaCl2 x 2 H2O 0.01 g/l Tween 80 Resazurin Distilled water
35445MEDIUM 20 - for Anaerobic bacteriayesAgar (15.000 g);Glucose (5.000 g);Yeast extract (20.000 g);Tryptone (30.000 g);Cysteine hydrochloride (0.500 g);distilled water (1000.000 ml);Hemin solution -M00149 (25.000 ml)
116806CIP Medium 20yeshttps://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=20

culture temp

@refgrowthtypetemperature
8828positivegrowth37
35445positivegrowth37
67770positivegrowth37

Physiology and metabolism

oxygen tolerance

@refoxygen tolerance
8828anaerobe
116806anaerobe

spore formation

  • @ref: 125439
  • spore formation: no
  • confidence: 94.9

murein

  • @ref: 8828
  • murein short key: A21.07
  • type: A4ß L-Orn-D-Ser-D-Asp

metabolite utilization

@refChebi-IDmetaboliteutilization activitykind of utilization tested
11680617108D-arabinose-degradation
11680615824D-fructose+degradation
11680617634D-glucose+degradation
11680665327D-xylose-degradation
11680617057cellobiose-degradation
11680617716lactose+degradation
11680617306maltose-degradation
11680617814salicin-degradation
11680617992sucrose+degradation
1168064853esculin-hydrolysis
11680617632nitrate-reduction
11680616301nitrite-reduction
6837118305arbutin-builds acid from
6837127613amygdalin-builds acid from
68371320061methyl alpha-D-glucopyranoside-builds acid from
6837116813galactitol-builds acid from
6837162345L-rhamnose-builds acid from
68371Potassium 2-ketogluconate-builds acid from
6837124265gluconate-builds acid from
6837118403L-arabitol-builds acid from
6837118333D-arabitol-builds acid from
6837118287L-fucose-builds acid from
6837128847D-fucose-builds acid from
6837162318D-lyxose-builds acid from
6837132528turanose-builds acid from
6837128066gentiobiose-builds acid from
6837117151xylitol-builds acid from
6837128087glycogen-builds acid from
6837128017starch-builds acid from
6837116634raffinose-builds acid from
683716731melezitose-builds acid from
6837115443inulin-builds acid from
6837127082trehalose-builds acid from
6837117057cellobiose-builds acid from
6837117814salicin-builds acid from
6837159640N-acetylglucosamine-builds acid from
6837143943methyl alpha-D-mannoside-builds acid from
6837117924D-sorbitol-builds acid from
6837116899D-mannitol-builds acid from
6837117268myo-inositol-builds acid from
6837174863methyl beta-D-xylopyranoside-builds acid from
6837115963ribitol-builds acid from
6837165328L-xylose-builds acid from
6837165327D-xylose-builds acid from
6837116988D-ribose-builds acid from
6837130849L-arabinose-builds acid from
6837117108D-arabinose-builds acid from
6837117113erythritol-builds acid from
6837117754glycerol-builds acid from

antibiotic resistance

  • @ref: 116806
  • ChEBI: 6909
  • metabolite: metronidazole
  • is antibiotic: yes
  • is sensitive: no
  • is resistant: yes

metabolite production

  • @ref: 116806
  • Chebi-ID: 35581
  • metabolite: indole
  • production: no

enzymes

@refvalueactivityec
68382alpha-fucosidase-3.2.1.51
68382alpha-mannosidase-3.2.1.24
68382N-acetyl-beta-glucosaminidase+3.2.1.52
68382alpha-glucosidase+3.2.1.20
68382beta-glucuronidase-3.2.1.31
68382alpha-galactosidase+3.2.1.22
68382beta-galactosidase+3.2.1.23
68382acid phosphatase-3.1.3.2
68382naphthol-AS-BI-phosphohydrolase-
68382alpha-chymotrypsin-3.4.21.1
68382trypsin-3.4.21.4
68382valine arylamidase-
68382cystine arylamidase-3.4.11.3
68382leucine arylamidase+3.4.11.1
68382lipase (C 14)-
68382esterase lipase (C 8)-
68382esterase (C 4)-
68382alkaline phosphatase-3.1.3.1
116806oxidase-
116806beta-galactosidase-3.2.1.23
116806gelatinase-
116806amylase+
116806DNase-
116806caseinase+3.4.21.50
116806catalase-1.11.1.6
116806tween esterase-
116806lecithinase-
116806lipase-
116806protease-
116806urease-3.5.1.5
68382beta-glucosidase-3.2.1.21

API zym

@refControlAlkaline phosphataseEsteraseEsterase LipaseLipaseLeucine arylamidaseValine arylamidaseCystine arylamidaseTrypsinalpha- ChymotrypsinAcid phosphataseNaphthol-AS-BI-phosphohydrolasealpha- Galactosidasebeta- Galactosidasebeta- Glucuronidasealpha- Glucosidasebeta- GlucosidaseN-acetyl-beta- glucosaminidasealpha- Mannosidasealpha- Fucosidase
116806-----+------++-+-+--

API 50CHac

@refQGLYERYDARALARARIBDXYLLXYLADOMDXGALGLUFRUMNESBERHADULINOMANSORMDMMDGNAGAMYARBESCSALCELMALLACMELSACTREINUMLZRAFAMDGLYGXLTGENTURLYXTAGDFUCLFUCDARLLARLGNT2KG5KG
8828------------+------------+-----------------------+
8828----------+++------------+---++-------------------
8828----------++++/-+/-----------+--+/-+++/-------------------
8828----------+++------------+---++-------------------
8828----------+++------------+---++-------------------
8828----------+/-++----------------++/-------------------+/-
116806-----------------------------------------+/-------+/-

API biotype100

@refGLUFRUGALTREMNESBEMELSACRAFMTEMALLACLTEMbGaMaGaCELGENMbGuESCRIBARAXYLPLERHAFUCMLZDARLLARLXLTDULTAGGLYINOMANMTLTURSORADOHBGLYXERYMDG3MDGSATMUCLTATDTATMTATDMLTLMLTCATETATETTECITGRTGAT2KG5KGTRYNAGGNTPACPATpOBEQATGTEmOBEBATPPATCMTTGEBETPCEABTHINLATCAPCYTHISSUCFUMGREGYTAVTETNTTNGLNITA3OBUAPTGTTPRODALALALASERMNTPROPTYR2KT
116806---------------------------------------------------------------------------------------------------

Isolation, sampling and environmental information

isolation

@refsample type
8828stool of breast-fed infant
67770Feces of a breast-fed infant
116806Human, Child, feces

isolation source categories

Cat1Cat2Cat3
#Host#Human#Child
#Host Body Product#Gastrointestinal tract#Feces (Stool)

taxonmaps

  • @ref: 69479
  • File name: preview.99_669.png
  • url: https://microbeatlas.org/index.html?action=taxon&taxon_id=90_24;96_412;97_467;98_538;99_669&stattab=map
  • Last taxonomy: Bifidobacterium bifidum subclade
  • 16S sequence: U25952
  • Sequence Identity:
  • Total samples: 187487
  • soil counts: 1947
  • aquatic counts: 6270
  • animal counts: 178528
  • plant counts: 742

Safety information

risk assessment

@refbiosafety levelbiosafety level comment
88281Risk group (German classification)
1168061Risk group (French classification)

Sequence information

16S sequences

@refdescriptionaccessionlengthdatabaseNCBI tax ID
20218Bifidobacterium bifidum (ATCC 29521) 16S ribosomal RNA gene, partialM84777642nuccore1681
20218Bifidobacterium bifidum DSM 20456 16S ribosomal RNA gene, partial sequenceHM0075781344nuccore500634
20218Bifidobacterium bifidum DSM 20456 = JCM 1255 16S ribosomal RNA gene and 16S-23S ribosomal RNA intergenic spacer, partial sequenceJQ347252742nuccore500634
2021816S rRNA [Bifidobacterium bifidum, DSM 20456T, Genomic, 1532 nt]S836241532nuccore1681
20218Bifidobacterium bifidum gene for 16S rRNA, partial sequence, strain: JCM 1255AB116283477nuccore500634
20218Bifidobacterium bifidum gene for 16S rRNA, partial sequence, strain: JCM 1255AB507078668nuccore500634
20218Bifidobacterium bifidum strain KCTC 3202 16S ribosomal RNA gene, partial sequenceGU3618131480nuccore1681
20218Bifidobacterium bifidum strain KCTC 3202 16S ribosomal RNA gene, partial sequenceU259511488nuccore1681
20218Bifidobacterium bifidum KCTC 3202 16S rRNA geneU259521488nuccore1681
20218Bifidobacterium bifidum gene for 16S rRNA, partial sequence, strain: NBRC 100015AB6811291453nuccore1681
67770Bifidobacterium bifidum gene for 16S ribosomal RNA, partial sequenceAB4373561519nuccore1681
67770B.bifidum small subunit ribosomal RNA geneM380181532nuccore500634
124043Bifidobacterium bifidum gene for 16S ribosomal RNA, partial sequence, strain: JCM 1255.LC0718041422nuccore500634

Genome sequences

@refdescriptionaccessionassembly leveldatabaseNCBI tax ID
66792Bifidobacterium bifidum NCTC13001GCA_900637095completencbi1681
66792Bifidobacterium bifidum ATCC 29521 = JCM 1255 = DSM 20456GCA_001025135completencbi500634
66792Bifidobacterium bifidum ATCC 29521 = JCM 1255 = DSM 20456 Bifidobacterium_bifidum_MC1GCA_901212485scaffoldncbi500634
66792Bifidobacterium bifidum ATCC 29521 = JCM 1255500634.3wgspatric500634
66792Bifidobacterium bifidum ATCC 29521 = JCM 1255 = DSM 20456500634.6completepatric500634
66792Bifidobacterium bifidum ATCC 29521 = JCM 1255 = DSM 20456500634.4wgspatric500634
66792Bifidobacterium bifidum ATCC 29521 = JCM 1255 = DSM 20456 strain Bifidobacterium_bifidum_MC1500634.12wgspatric500634
66792Bifidobacterium bifidum strain LMG 110411681.23wgspatric1681
66792Bifidobacterium bifidum strain NCTC130011681.149completepatric1681
66792Bifidobacterium bifidum LMG 110412597490229draftimg1681
66792Bifidobacterium bifidum ATCC 295212848061456completeimg500634
66792Bifidobacterium bifidum ATCC 295212700989374draftimg500634
66792Bifidobacterium bifidum ATCC 295212541047090draftimg500634
67770Bifidobacterium bifidum ATCC 29521 = JCM 1255 = DSM 20456GCA_000466525scaffoldncbi500634
67770Bifidobacterium bifidum ATCC 29521 = JCM 1255 = DSM 20456GCA_000771485contigncbi500634
67770Bifidobacterium bifidum LMG 11041GCA_000741085contigncbi1681

Genome-based predictions

predictions

@refmodeltraitdescriptionpredictionconfidencetraining_data
125438gram-positivegram-positivePositive reaction to Gram-stainingyes86.115no
125438anaerobicanaerobicAbility to grow under anoxygenic conditions (including facultative anaerobes)yes77.388no
125438aerobicaerobicAbility to grow under oxygenic conditions (including facultative aerobes)no91.027no
125438spore-formingspore-formingAbility to form endo- or exosporesno87.818no
125438thermophilethermophilicAbility to grow at temperatures above or equal to 45°Cno94.967yes
125438motile2+flagellatedAbility to perform flagellated movementno93no
125439BacteriaNetspore_formationAbility to form endo- or exosporesno94.9
125439BacteriaNetmotilityAbility to perform movementno51.8
125439BacteriaNetgram_stainReaction to gram-stainingpositive78.2
125439BacteriaNetoxygen_toleranceOxygenic conditions needed for growthanaerobe76.8

External links

@ref: 8828

culture collection no.: DSM 20456, ATCC 29521, JCM 1255, BCRC 11845, BCRC 14615, CCUG 18364, CCUG 45217, CECT 870, CGMCC 1.2212, CIP 56.7, HAMBI 1380, IFO 14252, KCTC 3202, KCTC 3281, LMG 11041, LMG 8810, NBRC 100015, NBRC 14252, NCAIM B.02021, NCFB 2715, NCIMB 702715, NCTC 13001, VTT E-97795, NCDO 2715

straininfo link

  • @ref: 71340
  • straininfo: 1238

literature

topicPubmed-IDtitleauthorsjournalDOIyearmeshtopic2
Phylogeny1371060Phylogenetic evidence for the transfer of Eubacterium suis to the genus Actinomyces as Actinomyces suis comb. nov.Ludwig W, Kirchhof G, Weizenegger M, Weiss NInt J Syst Bacteriol10.1099/00207713-42-1-1611992Actinomyces/*classification/genetics, Base Sequence, Eubacterium/*classification/genetics, Molecular Sequence Data, RNA, Bacterial/*chemistry, RNA, Ribosomal, 16S/*chemistryGenetics
Metabolism1908865Binding of mutagens by fractions of the cell wall skeleton of lactic acid bacteria on mutagens.Zhang XB, Ohta YJ Dairy Sci10.3168/jds.S0022-0302(91)78306-91991Bifidobacterium/*metabolism, Cell Wall/metabolism, Humans, Lactobacillus acidophilus/*metabolism, Lactococcus lactis/metabolism/ultrastructure, Mutagens/*metabolism, Neoplasms/*prevention & control, Streptococcus/*metabolism/ultrastructurePathogenicity
Metabolism2071710In vitro binding of mutagenic pyrolyzates to lactic acid bacterial cells in human gastric juice.Zhang XB, Ohta YJ Dairy Sci10.3168/jds.S0022-0302(91)78221-01991Calcium Chloride/pharmacology, Carbolines/*metabolism, Freeze Drying, Gastric Juice/*microbiology, Hot Temperature, Humans, Hydrogen-Ion Concentration, Imidazoles/*metabolism, Magnesium Chloride/pharmacology, Mutagens/*metabolism, Sodium Chloride/pharmacology, Streptococcus/growth & development/*metabolismStress
Enzymology7745146Viability and enzymatic activity of bifidobacteria in milk.Hughes DB, Hoover DGJ Dairy Sci10.3168/jds.S0022-0302(95)76634-61995Animals, Bifidobacterium/*enzymology/*growth & development, Cold Temperature, Freezing, Milk/*microbiology, alpha-Galactosidase/*metabolismMetabolism
Transcriptome10510720Sequence analysis of 16S rRNA genes amplified from two ribosomal RNA gene clusters of Bifidobacterium bifidum.Yoon JH, Yim DK, Goodfellow M, Park YHAntonie Van Leeuwenhoek10.1023/a:10020251004441999Bifidobacterium/*genetics, Blotting, Southern, DNA, Ribosomal/chemistry, Polymerase Chain Reaction, RNA, Bacterial/*chemistry, RNA, Ribosomal, 16S/*chemistry, Sequence Analysis, DNAPhylogeny
Enzymology15606767Molecular identification of monomeric aspartate racemase from Bifidobacterium bifidum.Yamashita T, Ashiuchi M, Ohnishi K, Kato S, Nagata S, Misono HEur J Biochem10.1111/j.1432-1033.2004.04445.x2004Amino Acid Isomerases/chemistry/isolation & purification/*metabolism, Amino Acid Sequence, Base Sequence, Bifidobacterium/*enzymology, Cloning, Molecular, DNA Primers, Electrophoresis, Polyacrylamide Gel, Enzyme Stability, Hydrogen-Ion Concentration, Kinetics, Molecular Sequence Data, Molecular Weight, Recombinant Proteins/chemistry/isolation & purification/metabolism, Sequence Homology, Amino Acid, Substrate SpecificityPhylogeny
Pathogenicity15960982Molecular properties and prebiotic effect of inulin obtained from artichoke (Cynara scolymus L.).Lopez-Molina D, Navarro-Martinez MD, Rojas Melgarejo F, Hiner AN, Chazarra S, Rodriguez-Lopez JNPhytochemistry10.1016/j.phytochem.2005.04.0032005Bifidobacterium/drug effects/*growth & development, Cynara scolymus/*chemistry, Feces/microbiology, Gas Chromatography-Mass Spectrometry, Humans, Infant, Inulin/chemistry/*isolation & purification/pharmacology, Molecular Weight, Plant Extracts/isolation & purification/pharmacology, Polymers, Spectroscopy, Fourier Transform InfraredEnzymology
Pathogenicity17387552Basic characteristics of Sporolactobacillus inulinus BCRC 14647 for potential probiotic properties.Huang HY, Huang SY, Chen PY, King VA, Lin YP, Tsen JHCurr Microbiol10.1007/s00284-006-0496-52007Acids/pharmacology, Bacillaceae/drug effects/*physiology, Bacterial Adhesion, Bifidobacterium/physiology, Bile Acids and Salts/pharmacology, Caco-2 Cells, Humans, Hydrogen-Ion Concentration, Lactobacillaceae, Lactobacillus acidophilus/physiology, Microbial Viability, *Probiotics, Spores, Bacterial/physiology
Pathogenicity17993372Incorporation of citrus fibers in fermented milk containing probiotic bacteria.Sendra E, Fayos P, Lario Y, Fernandez-Lopez J, Sayas-Barbera E, Perez-Alvarez JAFood Microbiol10.1016/j.fm.2007.09.0032007Animals, Bifidobacterium/*growth & development, Citrus/*chemistry, Colony Count, Microbial, Fermentation, Food Handling/methods, Food Preservation/*methods, Humans, Lactobacillus acidophilus/*growth & development, Lactobacillus casei/*growth & development, Milk/*microbiology, Models, Biological, Probiotics, Time Factors
Metabolism22447584Role of extracellular transaldolase from Bifidobacterium bifidum in mucin adhesion and aggregation.Gonzalez-Rodriguez I, Sanchez B, Ruiz L, Turroni F, Ventura M, Ruas-Madiedo P, Gueimonde M, Margolles AAppl Environ Microbiol10.1128/AEM.08024-112012*Bacterial Adhesion, Bifidobacterium/*enzymology/physiology, Cell Membrane/metabolism, Epithelial Cells/*microbiology, HT29 Cells, Humans, Intestines/cytology/*microbiology, Membrane Proteins, Mucins/*chemistry, Probiotics, Transaldolase/*metabolismPathogenicity
Metabolism23332852Antimicrobial potential for the combination of bovine lactoferrin or its hydrolysate with lactoferrin-resistant probiotics against foodborne pathogens.Chen PW, Jheng TT, Shyu CL, Mao FCJ Dairy Sci10.3168/jds.2012-61122013Animals, Anti-Infective Agents/administration & dosage/*therapeutic use, Bifidobacterium/metabolism, Cattle, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Lactobacillus/metabolism, Lactobacillus acidophilus/metabolism, Lactobacillus rhamnosus/metabolism, Lactoferrin/administration & dosage/drug effects/*therapeutic use, Pediococcus/metabolism, Probiotics/administration & dosage/*therapeutic use, Protein Hydrolysates, Salmonella typhimurium/drug effectsPathogenicity
Metabolism24014530BopA does not have a major role in the adhesion of Bifidobacterium bifidum to intestinal epithelial cells, extracellular matrix proteins, and mucus.Kainulainen V, Reunanen J, Hiippala K, Guglielmetti S, Vesterlund S, Palva A, Satokari RAppl Environ Microbiol10.1128/AEM.01993-132013*Bacterial Adhesion, Bacterial Proteins/genetics/*metabolism, Bifidobacterium/genetics/*physiology, Caco-2 Cells, Cell Membrane, Cloning, Molecular, Epithelial Cells/*microbiology, Escherichia coli/genetics/metabolism, Extracellular Matrix Proteins/metabolism, Genes, Bacterial, HT29 Cells, Humans, Intestinal Mucosa/*cytology/microbiology, Lipoproteins/genetics/metabolism, Membrane Proteins/genetics/*metabolism, Mucus/microbiology, Probiotics, Protein Binding, Recombinant Proteins/genetics/metabolismEnzymology
Pathogenicity24916115Influence of bovine lactoferrin on the growth of selected probiotic bacteria under aerobic conditions.Chen PW, Ku YW, Chu FYBiometals10.1007/s10534-014-9758-z2014Aerobiosis, Anaerobiosis, Animals, Anti-Bacterial Agents/administration & dosage, Antimicrobial Cationic Peptides/administration & dosage/physiology, Bifidobacterium/drug effects/growth & development, Cattle, Escherichia coli/drug effects/growth & development/pathogenicity, Lactobacillus/drug effects/growth & development, Lactoferrin/*administration & dosage/*physiology, Microbial Sensitivity Tests, Probiotics/*administration & dosage
Pathogenicity25099661Fourier transform infra-red spectroscopy and flow cytometric assessment of the antibacterial mechanism of action of aqueous extract of garlic (Allium sativum) against selected probiotic Bifidobacterium strains.Booyens J, Thantsha MSBMC Complement Altern Med10.1186/1472-6882-14-2892014Anti-Bacterial Agents/chemistry/*pharmacology, Bifidobacterium/*drug effects, Flow Cytometry/methods, Garlic/*chemistry, Microbial Viability/drug effects, Plant Extracts/chemistry/*pharmacology, *Probiotics, Spectroscopy, Fourier Transform Infrared/methods
25276184Microencapsulation of Probiotics by Calcium Alginate-gelatinized Starch with Chitosan Coating and Evaluation of Survival in Simulated Human Gastro-intestinal Condition.Khosravi Zanjani MA, Ghiassi Tarzi B, Sharifan A, Mohammadi NIran J Pharm Res2014
Metabolism25542994Comparison of mupirocin-based media for selective enumeration of bifidobacteria in probiotic supplements.Bunesova V, Musilova S, Geigerova M, Pechar R, Rada VJ Microbiol Methods10.1016/j.mimet.2014.12.0162014Anti-Bacterial Agents/*metabolism, Bacterial Load/*methods, Bifidobacterium/drug effects/*growth & development, Colony Count, Microbial/*methods, Culture Media/*chemistry, Mupirocin/*metabolism, Probiotics/*analysisPathogenicity
25866754A Novel Lactobacillus casei LP1 Producing 1,4-Dihydroxy-2-Naphthoic Acid, a Bifidogenic Growth Stimulator.Kang JE, Kim TJ, Moon GSPrev Nutr Food Sci10.3746/pnf.2015.20.1.782015
Genetics26133927Complete genome sequence of Bifidobacterium bifidum JCM 1255(T) isolated from feces of a breast-fed infant.Morita H, Toh H, Oshima K, Nakano A, Shindo C, Komiya K, Arakawa K, Suda W, Honda K, Hattori MJ Biotechnol10.1016/j.jbiotec.2015.06.4132015Base Composition, Bifidobacterium/*genetics, Breast Feeding, Feces/*microbiology, Genome Size, *Genome, Bacterial, Humans, Infant, Molecular Sequence Annotation, Molecular Sequence Data, Sequence Analysis, DNA/*methodsPathogenicity
Pathogenicity26863255Efficacy of oral Bifidobacterium bifidum ATCC 29521 on microflora and antioxidant in mice.Wang BG, Xu HB, Xu F, Zeng ZL, Wei HCan J Microbiol10.1139/cjm-2015-06852015Animals, Antioxidants/*pharmacology, *Bifidobacterium, *Gastrointestinal Microbiome, Humans, Male, Mice, Mice, Inbred BALB C, Mouth/*microbiology, Oxidative Stress
Pathogenicity27018325Effect of oligosaccharides on the adhesion of gut bacteria to human HT-29 cells.Altamimi M, Abdelhay O, Rastall RAAnaerobe10.1016/j.anaerobe.2016.03.0102016Bacterial Adhesion/*drug effects, Bacteroides/drug effects/physiology, Bacteroides fragilis/drug effects/physiology, Bifidobacterium/drug effects/physiology, Clostridium/drug effects/physiology, Faecalibacterium/drug effects/physiology, Gastrointestinal Microbiome/*drug effects, HT29 Cells, Humans, Lactobacillus casei/drug effects/physiology, Mucins/metabolism, Oligosaccharides/*pharmacology, Prebiotics/*analysis, Species SpecificityPhylogeny
Pathogenicity27372578Integration of genomic and proteomic data to identify candidate genes in HT-29 cells after incubation with Bifidobacterium bifidum ATCC 29521.Wang BG, Wu Y, Qiu L, Shah NP, Xu F, Wei HJ Dairy Sci10.3168/jds.2015-105772016Animals, Bifidobacterium bifidum/*growth & development, Caco-2 Cells, Databases, Genetic, Down-Regulation, Epithelial Cells/*metabolism/microbiology, Gastrointestinal Microbiome, Gene Ontology, HT29 Cells, Humans, Intestines/cytology/microbiology, Mice, Mice, Inbred BALB C, Probiotics, *Proteome, Proteomics, Reproducibility of Results, Up-RegulationProteome
Metabolism29120775Preparation and prebiotic potential of pectin oligosaccharides obtained from citrus peel pectin.Zhang S, Hu H, Wang L, Liu F, Pan SFood Chem10.1016/j.foodchem.2017.10.0712017Bifidobacterium/drug effects/growth & development/metabolism, Hydrogen Peroxide/metabolism, Monosaccharides/analysis, Oligosaccharides/chemistry/*pharmacology, Pectins/*chemistry, *PrebioticsPathogenicity
Phylogeny29300153Bifidobacterium catulorum sp. nov., a novel taxon from the faeces of the baby common marmoset (Callithrix jacchus).Modesto M, Michelini S, Oki K, Biavati B, Watanabe K, Mattarelli PInt J Syst Evol Microbiol10.1099/ijsem.0.0025452018Aldehyde-Lyases/genetics, Animals, Bacterial Typing Techniques, Base Composition, Bifidobacterium/*classification/genetics/isolation & purification, Callithrix/*microbiology, Chaperonin 60/genetics, DNA, Bacterial/genetics, Feces/microbiology, Genes, Bacterial, Peptidoglycan/chemistry, *Phylogeny, RNA, Ribosomal, 16S/genetics, Sequence Analysis, DNATranscriptome
29881432Promoting Probiotics Survival by Microencapsualtion with Hylon Starch and Genipin Cross-linked Coatings in Simulated Gastro-intestinal Condition and Heat Treatment.Khosravi Zanjani MA, Ehsani MR, Ghiassi Tarzi B, Sharifan AIran J Pharm Res2018
Phylogeny30789326Characterization of the phylogenetic diversity of five novel species belonging to the genus Bifidobacterium: Bifidobacterium castoris sp. nov., Bifidobacterium callimiconis sp. nov., Bifidobacterium goeldii sp. nov., Bifidobacterium samirii sp. nov. and Bifidobacterium dolichotidis sp. nov.Duranti S, Lugli GA, Napoli S, Anzalone R, Milani C, Mancabelli L, Alessandri G, Turroni F, Ossiprandi MC, van Sinderen D, Ventura MInt J Syst Evol Microbiol10.1099/ijsem.0.0033062019Animals, Bacterial Typing Techniques, Base Composition, Bifidobacterium/*classification, Callithrix/*microbiology, DNA, Bacterial/genetics, Feces/microbiology, Genes, Bacterial, *Phylogeny, RNA, Ribosomal, 16S/genetics, Rodentia/*microbiology, Saimiri/*microbiology, Sequence Analysis, DNATranscriptome
Metabolism30880149Purified thioredoxin reductase from O2-sensitive Bifidobacterium bifidum degrades H2O2 by interacting with alkyl hydroperoxide reductase.Satoh T, Todoroki M, Kobayashi K, Niimura Y, Kawasaki SAnaerobe10.1016/j.anaerobe.2019.03.0122019Anaerobiosis, Bifidobacterium bifidum/*enzymology/metabolism, Hydrogen Peroxide/*metabolism, Oxidants/*metabolism, Oxygen/metabolism/toxicity, Peroxiredoxins/*metabolism, Thioredoxin-Disulfide Reductase/isolation & purification/*metabolismEnzymology
Pathogenicity31965845Analysis of hypoxia-associated dendritic cells in colitic mice and effects of probiotics on IL-10 production in inflammatory dendritic-cells under hypoxia.Ogita T, Miyamoto J, Hirabayashi Y, Rossi M, Mazzarella G, Takahashi I, Tanabe S, Suzuki TBenef Microbes10.3920/BM2018.01712019Animals, Cell Differentiation, Cells, Cultured, Colitis/chemically induced, Colon/pathology, Dendritic Cells/immunology/*pathology, Female, Hypoxia/chemically induced/*immunology, Hypoxia-Inducible Factor 1, alpha Subunit/genetics, *Inflammation, Interleukin-10/*biosynthesis, Lymph Nodes/immunology/pathology, Mice, Mice, Inbred BALB C, Mucous Membrane/immunology/pathology, Oxygen/*metabolism, *ProbioticsBiotechnology
Phylogeny32065574Characterization of the phylogenetic diversity of two novel species belonging to the genus Bifidobacterium: Bifidobacterium cebidarum sp. nov. and Bifidobacterium leontopitheci sp. nov.Duranti S, Lugli GA, Viappiani A, Mancabelli L, Alessandri G, Anzalone R, Longhi G, Milani C, Ossiprandi MC, Turroni F, Ventura MInt J Syst Evol Microbiol10.1099/ijsem.0.0040322020Aldehyde-Lyases, Animals, Bacterial Typing Techniques, Base Composition, Base Sequence, Bifidobacterium/*classification/isolation & purification, Callimico/*microbiology, DNA, Bacterial/genetics, Fatty Acids/chemistry, Feces/microbiology, Genes, Bacterial, Leontopithecus/*microbiology, Peptidoglycan/chemistry, *Phylogeny, RNA, Ribosomal, 16S/genetics, Sequence Analysis, DNATranscriptome
Metabolism32145470Inhibitory effect of Bifidobacterium bifidum ATCC 29521 on colitis and its mechanism.Din AU, Hassan A, Zhu Y, Zhang K, Wang Y, Li T, Wang Y, Wang GJ Nutr Biochem10.1016/j.jnutbio.2020.1083532020Animals, Anti-Inflammatory Agents/pharmacology, Antioxidants/pharmacology, *Bifidobacterium bifidum, Colitis, Ulcerative/chemically induced/*drug therapy/metabolism, Colon/metabolism, Cytokines/metabolism, Dextran Sulfate/adverse effects, Disease Models, Animal, Dysbiosis/chemically induced/drug therapy, Gastrointestinal Microbiome/drug effects, Interleukin-1beta/metabolism, Male, Mice, Mice, Inbred C57BL, MicroRNAs/metabolism, NF-kappa B/metabolism, Probiotics/administration & dosage/*pharmacology, Tumor Necrosis Factor-alpha/metabolismPathogenicity
Metabolism33233577Utilization of Seafood Processing By-Products for Production of Proteases by Paenibacillus sp. TKU052 and Their Application in Biopeptides' Preparation.Doan CT, Tran TN, Nguyen VB, Nguyen AD, Wang SLMar Drugs10.3390/md181105742020Angiotensin-Converting Enzyme Inhibitors/metabolism/pharmacology, Animal Shells, Animals, Antioxidants/metabolism/pharmacology, Bacterial Proteins/isolation & purification/*metabolism, *Brachyura, Enzyme Stability, Fermentation, *Food Handling, *Industrial Microbiology, Paenibacillus/*enzymology, Peptide Hydrolases/isolation & purification/*metabolism, Peptides/*metabolism, Prebiotics, Proteolysis, *Seafood, Substrate Specificity, *Waste ProductsEnzymology
Phylogeny33686049Effects of Pretreatment with Bifidobacterium bifidum Using 16S Ribosomal RNA Gene Sequencing in a Mouse Model of Acute Colitis Induced by Dextran Sulfate Sodium.Weng YJ, Jiang DX, Liang J, Ye SC, Tan WK, Yu CY, Zhou YMed Sci Monit10.12659/MSM.9284782021Animals, Bacteria/genetics, Bifidobacterium bifidum/*metabolism, Colitis/*drug therapy/microbiology, Colitis, Ulcerative/genetics, Colon/pathology, Dextran Sulfate/adverse effects/pharmacology, Disease Models, Animal, Feces/microbiology, Female, Gastrointestinal Microbiome/*drug effects/genetics, Inflammatory Bowel Diseases/pathology, Mice, Mice, Inbred C57BL, Probiotics/therapeutic use, RNA, Ribosomal, 16S/geneticsMetabolism
34282567Evaluation of Microencapsulated Synbiotic Preparations Containing Lactobionic Acid.Goderska K, Kozlowski PAppl Biochem Biotechnol10.1007/s12010-021-03622-92021*Bifidobacterium bifidum, Capsules, Disaccharides/*chemistry, *Lactobacillales, Probiotics/*chemistry, *Synbiotics
34663045In vitro prebiotic evaluation of exopolysaccharides produced by marine isolated lactic acid bacteria.Hongpattarakere T, Cherntong N, Wichienchot S, Kolida S, Rastall RACarbohydr Polym10.1016/j.carbpol.2011.08.0852011

Reference

@idauthorscataloguedoi/urltitlejournalpubmed
8828Curators of the DSMZLeibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 20456)https://www.dsmz.de/collection/catalogue/details/culture/DSM-20456
20215Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.10.1099/ijsem.0.004332List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ
20218Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.10.1016/j.syapm.2013.11.002StrainInfo introduces electronic passports for microorganisms.Syst Appl Microbiol. 37: 42-50 201424321274
35445Curators of the CIPhttps://brclims.pasteur.fr/brcWeb/souche/detail/1/9010
66792Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmannhttps://diaspora-project.de/progress.html#genomesAutomatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
67770Curators of the JCMhttps://jcm.brc.riken.jp/en/
68371Automatically annotated from API 50CH acid
68382Automatically annotated from API zym
69479João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.https://microbeatlas.org/MicrobeAtlas 1.0 beta
71340Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.10.60712/SI-ID1238.1StrainInfo: A central database for resolving microbial strain identifiers
116806Curators of the CIPCollection of Institut Pasteur (CIP 56.7)https://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%2056.7
124043Isabel Schober, Julia KoblitzData extracted from sequence databases, automatically matched based on designation and taxonomy
125438Julia Koblitz, Lorenz Christian Reimer, Rüdiger Pukall, Jörg Overmann10.1101/2024.08.12.607695Predicting bacterial phenotypic traits through improved machine learning using high-quality, curated datasets
125439Philipp Münch, René Mreches, Martin Binder, Hüseyin Anil Gündüz, Xiao-Yin To, Alice McHardyhttps://github.com/GenomeNet/deepGdeepG: Deep Learning for Genome Sequence Data. R package version 0.3.1